MicroRNA-24 Is a Novel Regulator of Aldosterone and Cortisol Production in the Human Adrenal Cortex

  • Stacy Robertson
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Scott M. MacKenzie
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Samantha Alvarez-Madrazo
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Louise A. Diver
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Junjun Lin
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Paul M. Stewart
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Robert Fraser
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • John M. Connell
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).
  • Eleanor Davies
    From the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (S.R., S.M.M., S.A.-M., L.A.D., J.L., R.F., E.D.); Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom (P.M.S.); and Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, United Kingdom (J.M.C.).

抄録

<jats:p> Dysregulation of aldosterone or cortisol production can predispose to hypertension, as seen in aldosterone-producing adenoma, a form of primary aldosteronism. We investigated the role of microRNA (miRNA) in their production, with particular emphasis on the <jats:italic>CYP11B1</jats:italic> (11β-hydroxylase) and <jats:italic>CYP11B2</jats:italic> (aldosterone synthase) genes, which produce the enzymes responsible for the final stages of cortisol and aldosterone biosynthesis, respectively. Knockdown of Dicer1, a key enzyme in miRNA maturation, significantly altered <jats:italic>CYP11B1</jats:italic> and <jats:italic>CYP11B2</jats:italic> expression in a human adrenocortical cell line. Screening of nondiseased human adrenal and aldosterone-producing adenoma samples yielded reproducible but distinctive miRNA expression signatures for each tissue type, with levels of certain miRNA, including microRNA-24 (miR-24), differing significantly between the 2. Bioinformatic analysis identified putative binding sites for several miRNA, including miR-24, in the 3′ untranslated region of <jats:italic>CYP11B1</jats:italic> and <jats:italic>CYP11B2</jats:italic> mRNAs. In vitro manipulation of miR-24 confirmed its ability to modulate <jats:italic>CYP11B1</jats:italic> and <jats:italic>CYP11B2</jats:italic> expression, as well as cortisol and aldosterone production. This study demonstrates that Dicer-dependent miRNA, including miR-24, can post-transcriptionally regulate expression of the <jats:italic>CYP11B1</jats:italic> and <jats:italic>CYP11B2</jats:italic> genes. Normal adrenal tissue and aldosterone-producing adenoma differ significantly and reproducibly in their miRNA expression profiles, with miR-24 significantly downregulated in the latter. Adrenal miRNA may, therefore, be a novel and valid target for the therapeutic manipulation of corticosteroid biosynthesis. </jats:p>

収録刊行物

  • Hypertension

    Hypertension 62 (3), 572-578, 2013-09

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ